Ruth BEN YAKAR,Stela Gengrinovitch,Shoshi Tessler,Liat Flaishon
申请号：
US16738115
公开号：
US20200147117A1
申请日:
2020.01.09
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to combination therapies of a cytarabine conjugate and one or more anti-neoplastic agents for inhibiting cancer cell growth. In particular, the present invention relates to a conjugate of cytarabine and aspartic acid (BST-236) in combination with one or more additional anti-neoplastic agents for use in the treatment of hematological cancers.
